Randomized multicenter trial for the prevention of preterm delivery by testing for and treatment of bacterial vaginosis in the first trimester of pregnancy.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 18 Jun 2013

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clindamycin (Primary)
Indications Bacterial infections; Bacterial vaginosis; Preterm birth
Focus Therapeutic Use
Acronyms PREMEVA

Most Recent Events

05 Dec 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
05 Dec 2011 Trial acronym (PREMEVA) identified as reported by ClinicalTrials.gov.
09 Apr 2008 New trial record.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight